Cargando…

c-IAP1 and c-IAP2 Redundancy Differs between T and B Cells

Cellular Inhibitors of Apoptosis 1 and 2 (c-IAP1 and c-IAP2) are ubiquitin protein ligases (E3s) that constitutively ubiquitinate and induce proteasomal-mediated degradation of NF-κB Inducing Kinase (NIK) and repress non-canonical NF-κB activation. Mice expressing an E3-inactive c-IAP2 mutant (c-IAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giardino Torchia, Maria Letizia, Conze, Dietrich B., Ashwell, Jonathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684576/ https://www.ncbi.nlm.nih.gov/pubmed/23799077 http://dx.doi.org/10.1371/journal.pone.0066161

Ejemplares similares

Non-Canonical NF-κB Activation and Abnormal B Cell Accumulation in Mice Expressing Ubiquitin Protein Ligase-Inactive c-IAP2
por: Conze, Dietrich B., et al.
Publicado: (2010)

Correction: Non-Canonical NF-κB Activation and Abnormal B Cell Accumulation in Mice Expressing Ubiquitin Protein Ligase-Inactive c-IAP2
por: Conze, Dietrich B., et al.
Publicado: (2016)

Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
por: Darding, M, et al.
Publicado: (2011)

Effects of Physiological and Synthetic IAP Antagonism on c-IAP-Dependent Signaling
por: Kocab, Andrew J., et al.
Publicado: (2015)

IAP-IAP Complexes Required for Apoptosis Resistance of C. trachomatis–Infected Cells
por: Rajalingam, Krishnaraj, et al.
Publicado: (2006)

LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC
por: Yang, Chengcheng, et al.
Publicado: (2016)

Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells
por: Mitsuuchi, Y, et al.
Publicado: (2017)

Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment
por: Schwarzenbach, Christian, et al.
Publicado: (2021)

Cytoplasmic and Nuclear Functions of cIAP1
por: Zadoroznyj, Aymeric, et al.
Publicado: (2022)

Bivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signaling
por: Condon, Stephen M
Publicado: (2016)

IAP Workshop
Publicado: (1996)

Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
por: Friboulet, Luc, et al.
Publicado: (2010)

Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation
por: Gill, Catherine, et al.
Publicado: (2009)

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
por: Morón-Calvente, Virginia, et al.
Publicado: (2018)

Expression and Correlation of Cell-Free cIAP-1 and cIAP-2 mRNA in Breast Cancer Patients: A Study from India
por: Verma, Amit Kumar, et al.
Publicado: (2020)

IAP textbook of vaccines
por: Kabra, S. K.
Publicado: (2016)

IAPS Presidential Address
por: Ramadwar, Ravindra
Publicado: (2022)

E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding
por: Allègre, Jennifer, et al.
Publicado: (2018)

cIAP-1 Controls Innate Immunity to C. pneumoniae Pulmonary Infection
por: Prakash, Hridayesh, et al.
Publicado: (2009)

Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK
por: Zarnegar, Brian J., et al.
Publicado: (2008)

IAP Display: A Simple Method to Identify Mouse Strain Specific IAP Insertions
por: Ray, Akshay, et al.
Publicado: (2010)

Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression
por: Paschall, Amy V, et al.
Publicado: (2014)

c-IAP1 Binds and Processes PCSK9 Protein: Linking the c-IAP1 in a TNF-α Pathway to PCSK9-Mediated LDLR Degradation Pathway
por: Xu, Weiming, et al.
Publicado: (2012)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Development of rebunching cavities at IAP
por: Welsch, C P, et al.
Publicado: (2000)

IAPS Textbook of Pediatric Surgery
por: Jacobsen, Anette
Publicado: (2020)

IAPS Textbook of Pediatric Surgery
por: Raffensperger, John G.
Publicado: (2020)

Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency
por: Cheng, Le, et al.
Publicado: (2010)

IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition
por: Alicke, Bruno, et al.
Publicado: (2022)

Intestinal alkaline phosphatase (IAP, IAP Enhancer) attenuates intestinal inflammation and alleviates insulin resistance
por: Gao, Chenzhe, et al.
Publicado: (2022)

2nd IAP Astrophysics Meeting
por: Audouze, Jean, et al.
Publicado: (1986)

Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
por: Berthelet, Jean, et al.
Publicado: (2013)

5th IAP Astrophysics Meeting
por: Audouze, Jean, et al.
Publicado: (1990)

3rd IAP Astrophysics Meeting
por: Bergeron, Jacqueline, et al.
Publicado: (1987)

Layout of an Electrostatic Storage Ring at IAP
por: Welsch, C P, et al.
Publicado: (2001)

Targeting IAP proteins in combination with radiotherapy
por: Fulda, Simone
Publicado: (2015)

The abstracts of IAP meetings will not be covered in JAPID
por: Shirmohammadi, Adileh
Publicado: (2020)

Bidding Adieu to IAP Year 2022
por: Remesh Kumar, R
Publicado: (2022)

IIAEK Targets Intestinal Alkaline Phosphatase (IAP) to Improve Cholesterol Metabolism with a Specific Activation of IAP and Downregulation of ABCA1
por: Takeuchi, Asahi, et al.
Publicado: (2020)

8th IAP Meeting on Astrophysics Meeting
por: Dennefeld, M, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_6ii5td65eo26p2dddmapeepo4s